Phathom Pharmaceuticals (PHAT.US) Stock Community - Hot Topic Discussions

Event Tracking

Nov4

Phathom Pharmaceuticals Launches Phase 2 Clinical Trial for EoE

12:36

Oct30

TR | OpenAI Reiterates Hold Rating on Phathom Pharmaceuticals

14:08

Phathom Pharmaceuticals released FY2025 9 Months earnings on October 30 Pre-Market (EST), actual revenue USD 117.53 M, actual EPS USD -2.765

13:30

Phathom Pharmaceuticals released FY2025 Q3 earnings on October 30 Pre-Market (EST), actual revenue USD 49.5 M (forecast USD 46.99 M), actual EPS USD -0.4099 (forecast USD -0.545)

13:30

Oct27

Phathom Pharmaceuticals Reaffirmed with Hold Rating

14:42

Oct25

Phathom Pharmaceuticals Inc. publishes positive results for VOQUEZNA® in treating Non-Erosive Reflux Disease

13:59

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 49.5 M, Net Income -29.97 M, EPS -0.4083

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 39.5 M, Net Income -75.81 M, EPS -1.0461

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 28.52 M, Net Income -94.32 M, EPS -1.3105

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change